Ivabradine
Author:
Affiliation:
1. From School of Medicine, University of California San Francisco (M.A.P., J.R.T.); and Section of Cardiology, San Francisco Veterans Affairs Medical Center, CA (J.R.T.).
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference65 articles.
1. US Food and Drug Administration. Ivabradine: highlights of prescribing information. http://www.Accessdata.Fda.Gov/drugsatfda_docs/label/2015/206143orig1s000lbl.Pdf. 2015. Accessed December 12 2015.
2. European Medicines Agency. Ivabradine: European public assessment report. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004187/WC500193961.pdf. 2015. Accessed December 12 2015.
3. Meta-analysis: β-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure
4. Analysis of Randomized Controlled Trials on the Effect of Magnitude of Heart Rate Reduction on Clinical Outcomes in Patients With Systolic Chronic Heart Failure Receiving Beta-Blockers
5. Long‐term Cardiovascular Risks Associated With an Elevated Heart Rate: The Framingham Heart Study
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Systematic Review and Meta-Analysis of Randomised Controlled Trials Assessing Clinical and Haemodynamic Outcomes of Ivabradine in Heart Failure With Reduced Ejection Fraction Patients;Heart, Lung and Circulation;2024-07
2. Personalised perioperative dosing of ivabradine in noncardiac surgery: a single-centre, randomised, placebo-controlled, double-blind feasibility pilot trial;British Journal of Anaesthesia;2024-07
3. Beyond quadruple therapy: the potential roles for ivabradine, vericiguat, and omecamtiv mecarbil in the therapeutic armamentarium;Heart Failure Reviews;2024-06-29
4. Understanding Heart Failure: Evolution of Concepts and Treatments;Cardiologia Croatica;2024-06
5. Pacemaker Channels and the Chronotropic Response in Health and Disease;Circulation Research;2024-05-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3